BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences Announces Key Executive Appointments

Integra LifeSciences (IART)Integra LifeSciencesCommercial

Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (Nasdaq: IART), a global leader in medical

Related news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

SSKNStrata Skin Sciences2026-07-28 13:15 EST

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer

CVRXCVRx2026-06-09 11:30 EST

CVRx Announces Chief Financial Officer Transition

ADPTAdaptive Biotechnologies2026-05-29 11:30 EST

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research

ADPTAdaptive Biotechnologies2026-05-21 20:18 EST

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

PAVMPAVmed2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

NEPHNephros2026-07-06 11:00 EST

Nephros Announces Inclusion in the Russell Microcap® Index

XAIRBeyond Air2026-06-01 12:00 EST

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

PAVMPAVmed2026-08-05 12:46 EST

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

IARTIntegra LifeSciences2026-07-02 12:30 EST

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

IARTIntegra LifeSciences2026-06-23 12:00 EST

Integra LifeSciences Announces Key Executive Appointments

IARTIntegra LifeSciences2026-06-15 12:30 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Stock data

Close
17.10 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States